4 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities: Ketamine + midazolam - Procedural Sedation | Phase 1 | Unknown | Ain Shams University | 40 | 2019-03-06 | 2019-03-08 |
| A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia AADvac1 40 µg, AADvac1 160 µg - Primary Progressive Nonfluent Aphasia | Phase 1 | Unknown | Axon Neuroscience SE | 33 | 2017-07-31 | 2019-11-14 |
| Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. Wait first, then levetiracetam, Levetiracetam first, then wait - Aphasia, Stroke | Phase 1 | Unknown | Kessler Foundation | 50 | 2005-09-01 | 2021-02-17 |
| Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach Age-specific parenting newsletters and developmental toys, Parent-completed Ages & Stages Questionnaires, Clinic-based distribution of children's books - Developmental Disabilities, Language Development Disorders | Phase 1 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 600 | 2002-03-01 | 2005-06-24 |
Aphasia (1) · Aphasia, Primary Progressive (1) · Developmental Disabilities (1) · Language Development Disorders (1) · Learning Disabilities (1) · Pick Disease of the Brain (1) · Primary Progressive Nonfluent Aphasia (1) · Stroke (1) · Tauopathies (1)
Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Language Disorders (3) · Mental Disorders (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Neurodevelopmental Disorders (2) · Speech Disorders (2) · Aphasia (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1)
AADvac1 (1) · Ketamine (1) · Levetiracetam (1) · Midazolam (1)
Ain Shams University (1) · Axon Neuroscience SE (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Kessler Foundation (1)
United States (2) · Egypt (1) · Germany (1)
A.M. Barrett, MD (1) · Harris S. Huberman, MD (1) · Markus Otto, Prof (1)
2017 (1)